← Back to Search

Corticosteroid

Dextenza for Diabetic Retinopathy

Phase 4
Waitlist Available
Led By Robert Feldman, MD
Research Sponsored by Ophthalmic Consultants of the Capital Region
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This trial is testing whether a sustained-release steroid insert is better than usual steroid drops in preventing a certain complication after cataract surgery in diabetic patients.

Eligible Conditions
  • Diabetic Retinopathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dexamethasone
Secondary outcome measures
Difference patients with absence of anterior chamber (AC) cells at Day 30 post op
Difference patients with absence of anterior chamber (AC) cells at Day 60 post op
Difference patients with absence of anterior chamber (AC) cells at Day 7 post op
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DextenzaExperimental Treatment1 Intervention
Sustained release Dexamethasone 0.4mg
Group II: Prednisolone Acetate 1%Active Control1 Intervention
Prednisolone Acetate Ophthalmic drops

Find a Location

Who is running the clinical trial?

Ophthalmic Consultants of the Capital RegionLead Sponsor
Robert Feldman, MDPrincipal InvestigatorOphthalmic Consultants of the Capital Region
4 Previous Clinical Trials
165 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery
2020. "DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04362241.
All > Diabetic Retinopathy > Cataract
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top